AUREGEN BIOTHERAPEUTICS Trademark

Trademark Overview


On Thursday, April 13, 2017, a trademark application was filed for AUREGEN BIOTHERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the AUREGEN BIOTHERAPEUTICS trademark a serial number of 79214833. The federal status of this trademark filing is REGISTERED as of Tuesday, July 24, 2018. This trademark is owned by Auregen BioTherapeutics SA. The AUREGEN BIOTHERAPEUTICS trademark is filed in the Pharmaceutical Products, Computer & Software Products & Electrical & Scientific Products, Treatment & Processing of Materials Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

3D printing services; 3D printing services, namely, customized creation of three-dimensional parts using rapid prototyping equipment; 3D biological printing services; biological 3D printing services

Laboratory apparatus for the manufacture of living tissue and three-dimensional organs, namely, incubators and cell culture apparatus for laboratory use for the manufacture of living tissue and three dimensional organs; laboratory apparatus specially adapted for scientific research performed in laboratories for the manufacture of living tissue and three dimensional organs; bioreactors for cell culture; print heads for ink-jet printers; laboratory equipment for scientific use and research, namely, systems comprising a liquid distributor, an imaging facility being medical imaging equipment, related control software, and related analysis software, all of the aforementioned for in vivo use in the fields of therapeutic and aesthetic treatment

Biological implants, namely, a vital processed human or animal connective tissue; biological tissue for implantation; cells for medical use; human tissue for allografts; living cells for medical use; implants comprised of living tissue for guided tissue regeneration; implants comprising living tissue; implantable materials comprised of living tissue for use in guided tissue regeneration; skin grafts; surgical implants composed of living tissue; vascular grafts being living tissue; biological molecules to assist with the development of tissue, namely, peptides, polypeptides, nucleosides, amino acids; natural biomaterials for bone and tissue augmentation for medical use; natural biomaterials for bone filling for medical purposes; natural biomaterials for filling cartilage for medical purposes; surgical implants comprising living tissues; biological tissue cultures for medical purposes, all of the aforementioned for in vivo use in the fields of therapeutic and aesthetic treatment

Medical services in the field of cellular immunotherapy and transplant, excluding services used for a diagnosis; human cell and tissue bank services; medical services regarding the collection and preservation of cells for medical use, all of the aforementioned for in vivo use in the fields of therapeutic and aesthetic treatment

Technical research in the field of biomaterials, 3D bioprinting and tissue engineering; three-dimensional biological printing research; tissue engineering research; scientific and medical research and development in the field of bioprinting; research and development of 3D processes and technology; scientific services relating to the isolation and cultivation of human tissues and cells, excluding services used for a diagnosis; scientific and medical research and development in the field of the manufacture of tissue; development and culture of artificial tissue and cells in the nature of tissue engineering; tissue engineering services; industrial analysis and research services in the field of tissue engineering, all of the aforementioned for in vivo use in the fields of therapeutic and aesthetic treatment
auregen biotherapeutics

General Information


Serial Number79214833
Word MarkAUREGEN BIOTHERAPEUTICS
Filing DateThursday, April 13, 2017
Status700 - REGISTERED
Status DateTuesday, July 24, 2018
Registration Number5521659
Registration DateTuesday, July 24, 2018
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 8, 2018

Trademark Statements


Goods and Services3D printing services; 3D printing services, namely, customized creation of three-dimensional parts using rapid prototyping equipment; 3D biological printing services; biological 3D printing services
Goods and ServicesLaboratory apparatus for the manufacture of living tissue and three-dimensional organs, namely, incubators and cell culture apparatus for laboratory use for the manufacture of living tissue and three dimensional organs; laboratory apparatus specially adapted for scientific research performed in laboratories for the manufacture of living tissue and three dimensional organs; bioreactors for cell culture; print heads for ink-jet printers; laboratory equipment for scientific use and research, namely, systems comprising a liquid distributor, an imaging facility being medical imaging equipment, related control software, and related analysis software, all of the aforementioned for in vivo use in the fields of therapeutic and aesthetic treatment
Goods and ServicesBiological implants, namely, a vital processed human or animal connective tissue; biological tissue for implantation; cells for medical use; human tissue for allografts; living cells for medical use; implants comprised of living tissue for guided tissue regeneration; implants comprising living tissue; implantable materials comprised of living tissue for use in guided tissue regeneration; skin grafts; surgical implants composed of living tissue; vascular grafts being living tissue; biological molecules to assist with the development of tissue, namely, peptides, polypeptides, nucleosides, amino acids; natural biomaterials for bone and tissue augmentation for medical use; natural biomaterials for bone filling for medical purposes; natural biomaterials for filling cartilage for medical purposes; surgical implants comprising living tissues; biological tissue cultures for medical purposes, all of the aforementioned for in vivo use in the fields of therapeutic and aesthetic treatment
Pseudo MarkAUREGEN BIO THERAPEUTICS
Goods and ServicesMedical services in the field of cellular immunotherapy and transplant, excluding services used for a diagnosis; human cell and tissue bank services; medical services regarding the collection and preservation of cells for medical use, all of the aforementioned for in vivo use in the fields of therapeutic and aesthetic treatment
Disclaimer with Predetermined Text"BIOTHERAPEUTICS"
Goods and ServicesTechnical research in the field of biomaterials, 3D bioprinting and tissue engineering; three-dimensional biological printing research; tissue engineering research; scientific and medical research and development in the field of bioprinting; research and development of 3D processes and technology; scientific services relating to the isolation and cultivation of human tissues and cells, excluding services used for a diagnosis; scientific and medical research and development in the field of the manufacture of tissue; development and culture of artificial tissue and cells in the nature of tissue engineering; tissue engineering services; industrial analysis and research services in the field of tissue engineering, all of the aforementioned for in vivo use in the fields of therapeutic and aesthetic treatment

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, August 31, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus.
US Class Codes021, 023, 026, 036, 038
Class Status Code6 - Active
Class Status DateThursday, August 31, 2017
Primary Code009
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateThursday, August 31, 2017
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, August 31, 2017
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, August 31, 2017
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAuregen BioTherapeutics SA
Party Type30 - Original Registrant
Legal Entity Type33 - NOT AVAILABLE
AddressCH

Party NameAuregen BioTherapeutics SA
Party Type20 - Owner at Publication
Legal Entity Type33 - NOT AVAILABLE
AddressCH

Party NameAuregen BioTherapeutics SA
Party Type10 - Original Applicant
Legal Entity Type33 - NOT AVAILABLE
AddressCH

Trademark Events


Event DateEvent Description
Monday, July 24, 2023COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Saturday, December 14, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Saturday, December 14, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, November 23, 2018FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, November 6, 2018FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, November 6, 2018FINAL DISPOSITION PROCESSED
Wednesday, October 24, 2018FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, July 24, 2018REGISTERED-PRINCIPAL REGISTER
Tuesday, June 19, 2018LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Friday, June 15, 2018LIMITATION OF GOODS RECEIVED FROM IB
Tuesday, May 8, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 8, 2018PUBLISHED FOR OPPOSITION
Wednesday, April 18, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, March 30, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 23, 2018LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Friday, March 16, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 16, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, March 14, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 14, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 14, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, December 22, 2017LIMITATION OF GOODS RECEIVED FROM IB
Saturday, October 7, 2017REFUSAL PROCESSED BY IB
Saturday, September 16, 2017NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, September 16, 2017REFUSAL PROCESSED BY MPU
Wednesday, September 13, 2017NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, September 12, 2017NON-FINAL ACTION WRITTEN
Tuesday, September 5, 2017APPLICATION FILING RECEIPT MAILED
Thursday, August 31, 2017ASSIGNED TO EXAMINER
Thursday, August 31, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, August 25, 2017LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, August 24, 2017SN ASSIGNED FOR SECT 66A APPL FROM IB